Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Exercise Study in Patients With Lung Cancer [Phase 2]
An update on a Phase 2 exercise study in patients with non-small cell lung cancer. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update for GV1001 telomerase vaccine in patients with inoperable stage III non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
An observational study assessing ethnic differences in second-line pemetrexed treatment for non-small cell lung cancer, with results posted …
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer [Phase 3]
This clinical trial update describes a Phase 3 study comparing quality of life outcomes in patients with advanced non-squamous non-small cel…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating the combination of apricoxib and erlotinib in patients with recurrent non-small cell lung cancer has completed an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-03-30Clinical Trial Update: Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Pfizer-sponsored Phase 1/2 trial evaluated the efficacy of combining axitinib with pemetrexed and cisplatin in non-squamous non-small cell…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Phase I Combination Ixabepilone + Cisplatin [Phase 1]
Phase I trial update of ixabepilone in combination with cisplatin for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar [Phase 2]
Phase 2 clinical trial exploring using CT perfusion imaging to determine the normalization window during treatment of advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients [Phase 3]
Phase 3 trial comparing vandetanib (ZD6474) in combination with pemetrexed to pemetrexed alone in second-line non-small cell lung cancer has…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures [Phase 3]
Phase III study of ZD6474 (ZACTIMA) in patients with non-small cell lung cancer who failed prior EGFR therapy completed. Results were posted…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) [Phase 2]
Phase II trial comparing maintenance temozolomide versus observation in stable or responding stage III/IV Non-Small Cell Lung Cancer. The st…
-
CLINICAL_TRIALS research · 2012-03-23Clinical Trial Update: Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors [Phase 1]
Phase 1 safety study of XL147 (SAR245408) in combination with erlotinib in adults with solid tumors, including non-small cell lung cancer, h…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing carboplatin, paclitaxel, and radiation with or without thalidomide in stage III non-small cell lung cancer was ter…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Dendritic Cells in Lung Cancer [Phase 2]
Phase 2 trial update on dendritic cell therapy for non-small cell lung cancer; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer [Phase 1, Phase 2]
A Phase I/II trial of PTK787 with pemetrexed, with or without cisplatin, for non-small cell lung cancer and pleural mesothelioma has been te…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of anti-angiogenesis agent AG-013736 (cediranib) in advanced non-small cell lung cancer, with the study completed and r…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients [Phase 4]
Phase 4 trial update for non-squamous non-small cell lung cancer in Asian patients; the study completed and results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis [NA]
A clinical trial evaluating breathing-synchronized PET/CT for detecting malignant lung and liver lesions and assessing tumor glycolysis has …
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial update on talactoferrin added to standard chemotherapy for non-small cell lung cancer, reporting safety and efficacy findings.
-
CLINICAL_TRIALS trial_result · 2012-03-12Clinical Trial Update: Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating everolimus with whole-brain radiation therapy for brain metastases from non-small cell lung cancer was terminated…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC [Phase 2]
Phase II study evaluating first-line pemetrexed (Alimta) + gemcitabine (Gemzar) + bevacizumab (Avastin) in elderly patients with Stage IIIB/…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating the combination of irinotecan and gemcitabine for recurrent or progressive Stage III/IV non-small cell lung cance…
-
CLINICAL_TRIALS withdrawal · 2012-03-06Clinical Trial Update: Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy [Phase 2]
This update reports a Phase 2 trial evaluating the carboplatin, ixabepilone, and cetuximab combination in stage III or IV non-small cell lun…